European Medicines Agency to relocate to Amsterdam
The European Medicines Agency, which has been based in London since its establishment in 1995, will move to Amsterdam, the Netherlands. The need to relocate is a consequence of the U.K.’s withdrawal from the European Union.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
Blog
European Medicines Agency publishes Brexit guidance for pharma companies
The European Medicines Agency has published additional guidance for pharmaceutical companies to help them prepare for the United Kingdom’s withdrawal from the European Union.
-
News BriefEU regulator questions 'culture of compliance' with Digital Markets Act at Apple, Google
The European Commission released its preliminary findings last week regarding Apple and Google not complying with the Digital Markets Act. It issued orders to both companies regarding their business practice and plans to release all of its findings next week.
-
Premium‘Abject failure’: U.K. lawmakers sound off on FCA’s failed 'naming and shaming' enforcement
U.K. lawmakers slammed the country’s chief financial regulator’s hopes of “naming and shaming” firms as part of its efforts to beef up enforcement, denting its credibility in the process and questioning the leadership of its chief executive.